Finding synergies for 3Rs – Toxicokinetics and read‐across: Report from an EPAA partners' Forum

ABSTRACT The European Partnership for Alternative Approaches to Animal Testing (EPAA) convened a Partners' Forum Toxicokinetics and Read‐Across to provide an overview on research activities to develop in vitro toxicokinetics methods and physiologically‐based kinetic (PBK) models and to find synergies to enhance use of toxicokinetic data to strengthen read‐across. Currently, lacking toxicokinetic data often prevent the application of read‐across. Preferably, toxicokinetic data should be generated using in vitro and in silico tools and anchored towards human relevance. In certain sectors, PBK modelling is being used for risk assessment, but less so in others. Specific activities were identified to facilitate the use of in vitro and in silico toxicokinetic data to support read‐across: The collation of available tools indicating the parameters and applicability domains covered; endpoint‐specific guidance on toxicokinetics parameters required for read‐across; case studies exemplifying how toxicokinetic data help support read‐across. Activities to enhance the scientific robustness of read‐across include the further user‐friendly combination of read‐across tools and formal guidance by the authorities specifying the minimum information requirements to justify read‐across for a given toxicity endpoint. The EPAA was invited to continue dissemination activities and to explore possibilities to collate a contemporaneous list of open toxicokinetics tools that assist risk assessment.

[1]  M. Soufi,et al.  Assessment of an extended dataset of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption. , 2015, Regulatory toxicology and pharmacology : RTP.

[2]  N. Hewitt,et al.  Comparison of protocols measuring diffusion and partition coefficients in the stratum corneum , 2017, Journal of applied toxicology : JAT.

[3]  Curtis D. Klaassen,et al.  Casarett and Doull's Toxicology. The Basic Science of Poisons , 1981 .

[4]  Andrew P. Worth,et al.  EURL ECVAM strategy for achieving 3Rs impact in the assessment of toxicokinetics and systemic toxicity , 2015 .

[5]  Alexandra Maertens,et al.  Two Good Read-across Practice workshops. Making it work for you! , 2016, ALTEX.

[6]  Irene Manou,et al.  Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop. , 2015, Regulatory toxicology and pharmacology : RTP.

[7]  Manoj Aggarwal,et al.  Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition. , 2015, Regulatory toxicology and pharmacology : RTP.

[8]  Elmar Heinzle,et al.  In Silico Modeling for the Prediction of Dose and Pathway-Related Adverse Effects in Humans From In Vitro Repeated-Dose Studies. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Sneha Bhatia,et al.  An in silico skin absorption model for fragrance materials. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  G Würtzen,et al.  Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  M E Meek,et al.  New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis , 2013, Journal of applied toxicology : JAT.

[12]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[13]  Vikas Kumar,et al.  Prenatal exposure estimation of BPA and DEHP using integrated external and internal dosimetry: A case study , 2017, Environmental research.

[14]  Hans Verhagen,et al.  Editorial: OpenFoodTox: EFSA's open source toxicological database on chemical hazards in food and feed , 2017, EFSA journal. European Food Safety Authority.

[15]  George Loizou,et al.  MEGen: A Physiologically Based Pharmacokinetic Model Generator , 2011, Front. Pharmacol..

[16]  Malcolm Rowland,et al.  Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective , 2018, Clinical pharmacology and therapeutics.

[17]  Emilio Benfenati,et al.  QSAR models for predicting acute toxicity of pesticides in rainbow trout using the CORAL software and EFSA's OpenFoodTox database. , 2017, Environmental toxicology and pharmacology.

[18]  Ursula Gundert-Remy,et al.  Internal threshold of toxicological concern values: enabling route-to-route extrapolation , 2014, Archives of Toxicology.

[19]  P. Steinberg,et al.  Mode of action-based risk assessment of genotoxic carcinogens , 2020, Archives of Toxicology.

[20]  Robert G. Pearce,et al.  httk: R Package for High-Throughput Toxicokinetics. , 2017, Journal of statistical software.

[21]  Martina Klaric,et al.  Comparison of the Skin Penetration of 3 Metabolically Stable Chemicals Using Fresh and Frozen Human Skin , 2017, Skin Pharmacology and Physiology.

[22]  Andrew Worth,et al.  Title : The margin of internal exposure ( MOIE ) concept for dermal risk assessment based on oral toxicity data – a case study with caffeine Authors : , 2017 .

[23]  G Patlewicz,et al.  Building scientific confidence in the development and evaluation of read-across. , 2015, Regulatory toxicology and pharmacology : RTP.

[24]  Emilio Benfenati,et al.  The application of new HARD-descriptor available from the CORAL software to building up NOAEL models. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[25]  Ralf J. M. Weber,et al.  Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop. , 2017, Regulatory toxicology and pharmacology : RTP.

[26]  J B Houston,et al.  Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology , 2017, Drug Metabolism and Disposition.

[27]  Manoj Aggarwal,et al.  Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals. , 2016, Regulatory toxicology and pharmacology : RTP.

[28]  Bas J Blaauboer,et al.  On the incorporation of chemical-specific information in risk assessment. , 2008, Toxicology Letters.

[29]  Marta Schuhmacher,et al.  The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data. , 2018, The Science of the total environment.

[30]  A. M. Api,et al.  Criteria for the Research Institute for Fragrance Materials, Inc. (RIFM) safety evaluation process for fragrance ingredients. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  L M Sweeney,et al.  Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamide. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[32]  Daniel T. Chang,et al.  Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction , 2016, PLoS Comput. Biol..

[33]  Ewan D Booth,et al.  Use of read-across to simplify the toxicological assessment of a complex mixture of lysimeter leachate metabolites on the basis of chemical similarity and ADME behavior. , 2017, Regulatory toxicology and pharmacology : RTP.

[34]  Abigail Jacobs,et al.  Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests? , 2013, The AAPS Journal.

[35]  Andrew Worth,et al.  Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making , 2015, Environmental health perspectives.

[36]  Jacob de Boer,et al.  The European Long-range Research Initiative (LRI): A decade of contributions to human health protection, exposure modelling and environmental integrity. , 2015, Toxicology.

[37]  Bas J Blaauboer,et al.  Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice. , 2011, Regulatory toxicology and pharmacology : RTP.

[38]  Catherine Mahony,et al.  The SEURAT-1 approach towards animal free human safety assessment. , 2015, ALTEX.

[39]  Jacques Vervoort,et al.  Physiologically based kinetic modeling of the bioactivation of myristicin , 2016, Archives of Toxicology.

[40]  Andrew Worth,et al.  Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications , 2017, Regulatory toxicology and pharmacology : RTP.

[41]  A G Renwick,et al.  Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.

[42]  Barry Press,et al.  Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux. , 2011, Methods in molecular biology.

[43]  Marta Schuhmacher,et al.  Developing integrated PBPK/PD coupled mechanistic pathway model (miRNA-BDNF): An approach towards system toxicology. , 2017, Toxicology letters.

[44]  D. Weed Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[45]  Gerald T. Ankley,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment: Adverse outcome pathways in ecological risk assessment , 2011 .

[46]  R A Ford,et al.  Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[47]  R A Ford,et al.  Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.

[48]  Jie Shen,et al.  Toward Good Read-Across Practice (GRAP) , 2016 .

[49]  M. Soufi,et al.  Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption. , 2014, Regulatory toxicology and pharmacology : RTP.

[50]  Masoud Jamei,et al.  A multi-compartment liver model for the prediction of toxicokinetics , 2016 .

[51]  Jacob Lekker,et al.  The placing of plant protection products on the market , 2014 .

[52]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[53]  Claire Terry,et al.  Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use. , 2012, Regulatory toxicology and pharmacology : RTP.

[54]  H Rothe,et al.  Comparison of protocols for measuring cosmetic ingredient distribution in human and pig skin. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[55]  R Jeffrey Lewis,et al.  Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence , 2014, Journal of applied toxicology : JAT.

[56]  George Daston,et al.  Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. , 2012, Regulatory toxicology and pharmacology : RTP.

[57]  Ivonne M C M Rietjens,et al.  Mode of action based risk assessment of the botanical food-borne alkenylbenzene apiol from parsley using physiologically based kinetic (PBK) modelling and read-across from safrole. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[58]  J. Castell,et al.  Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism , 2003, Clinical pharmacokinetics.

[59]  H. Hasegawa,et al.  Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance. , 2018, Journal of pharmaceutical sciences.

[60]  Jeffrey Braithwaite,et al.  Bridges, brokers and boundary spanners in collaborative networks: a systematic review , 2013, BMC Health Services Research.

[61]  Hao Zhu,et al.  t4 report*: Toward Good Read-Across Practice (GRAP) Guidance , 2016, ALTEX.

[62]  Stuart Creton,et al.  Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation. , 2013, Regulatory toxicology and pharmacology : RTP.

[63]  Matthias Greiner,et al.  Guidance on the use of the weight of evidence approach in scientific assessments , 2017, EFSA journal. European Food Safety Authority.

[64]  Martina Klaric,et al.  Skin penetration in silico modeling-improvement by using in vitro data , 2017 .

[65]  Sieto Bosgra,et al.  Interpreting in vitro developmental toxicity test battery results: The consideration of toxicokinetics. , 2015, Reproductive toxicology.

[66]  A Worth,et al.  In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[67]  Fagen Zhang,et al.  An in vitro approach for comparative interspecies metabolism of agrochemicals , 2017, Regulatory toxicology and pharmacology : RTP.

[68]  George Loizou,et al.  EURL ECVAM WORKSHOP ON NEW GENERATION OF PHYSIOLOGICALLY-BASED KINETIC MODELS IN RISK ASSESSMENT , 2017 .

[69]  Robert G. Pearce,et al.  Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[70]  K Walton,et al.  Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[71]  Marta Schuhmacher,et al.  Review on crosstalk and common mechanisms of endocrine disruptors: Scaffolding to improve PBPK/PD model of EDC mixture. , 2017, Environment international.

[72]  Klaas Schildknegt,et al.  Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs , 2012, Drug Metabolism and Disposition.

[73]  T W Schultz,et al.  A strategy for structuring and reporting a read-across prediction of toxicity. , 2015, Regulatory toxicology and pharmacology : RTP.

[74]  Jürgen B. Bulitta,et al.  Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac , 2017, The AAPS Journal.

[75]  W. Casey,et al.  Application of Reverse Dosimetry to Compare In Vitro and In Vivo Estrogen Receptor Activity , 2015 .

[76]  Nathalie Seigneuret,et al.  The Innovative Medicines Initiative: an engine for regulatory science , 2014, Nature Reviews Drug Discovery.

[77]  Andrew Worth,et al.  Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods , 2017, Computational toxicology.

[78]  Terry W Schultz,et al.  Lessons learned from read-across case studies for repeated-dose toxicity. , 2017, Regulatory toxicology and pharmacology : RTP.